Neovasc Inc (DELISTED) (NVCN:DL)
30.03
0.00 (0.00%)
USD |
NASDAQ |
Apr 20, 16:00
Price Chart
Key Stats
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Europe and Rest of the World. The company earns revenue from one source, the Reducer. |
URL | https://www.neovasc.com |
Investor Relations URL | http://www.neovasc.com/neovasc-investment/ |
HQ State/Province | British Columbia |
Sector | |
Industry | |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | Mar. 10, 2022 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Europe and Rest of the World. The company earns revenue from one source, the Reducer. |
URL | https://www.neovasc.com |
Investor Relations URL | http://www.neovasc.com/neovasc-investment/ |
HQ State/Province | British Columbia |
Sector | |
Industry | |
Equity Style | Small Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | Mar. 10, 2022 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |